The place of conventional anthracyclins in first line metastatic breast cancer treatment

被引：0
|
作者：
Dourthe, L. -M. [1 ]
机构：
[1] Clin Orangerie, F-67000 Strasbourg, France
来源：
ONCOLOGIE | 2007年 / 9卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S12 / S19
页数：8
相关论文
共 50 条
  • [1] The place of conventional anthracyclins in first line metastatic breast cancer treatment
    Bonneterre, J.
    ONCOLOGIE, 2007, 9 : S9 - S11
  • [2] ANTHRACYCLINS IN THE TREATMENT OF METASTATIC BREAST CANCERS
    HERAIT, P
    PATHOLOGIE BIOLOGIE, 1990, 38 (08): : 859 - 859
  • [3] First-line treatment of metastatic breast cancer
    Trudeau, ME
    ANTI-CANCER DRUGS, 1996, 7 : 9 - 12
  • [4] Bevacizumab in first-line treatment of metastatic breast cancer
    Miles, David
    DRUGS, 2007, 67 (12) : 1800 - 1800
  • [5] BevacizumabIn First-Line Treatment of Metastatic Breast Cancer
    Lesley J. Scott
    Drugs, 2007, 67 : 1793 - 1799
  • [6] Bevacizumab in the first-line treatment of metastatic breast cancer
    Cameron, David
    EJC SUPPLEMENTS, 2008, 6 (06): : 21 - 28
  • [7] Octreotide as first-line treatment for women with metastatic breast cancer
    Ingle, JN
    Kardinal, CG
    Suman, VJ
    Krook, JE
    Hatfield, AK
    INVESTIGATIONAL NEW DRUGS, 1996, 14 (02) : 235 - 237
  • [8] First-line treatment with epirubicin and vinorelbine in metastatic breast cancer
    Vici, P
    Colucci, G
    Gebbia, V
    Amodio, A
    Giotta, F
    Belli, F
    Conti, F
    Gebbia, N
    Pezzella, G
    Valerio, MR
    Brandi, M
    Pisconti, S
    Durini, E
    Giannarelli, D
    Lopez, M
    JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (11) : 2689 - 2694
  • [9] Taxanes as a First-Line Systemic Treatment in Metastatic Breast Cancer
    Urquhart, Laura M.
    CLINICAL JOURNAL OF ONCOLOGY NURSING, 2013, 17 (01) : 15 - 21
  • [10] First-line Treatment of Metastatic Breast Cancer: Focus on Bevacizumab
    Fujii, Teruhiko
    Takahashi, Hiroki
    Matsubayashi, Roka Namoto
    Inoue, Yuka
    Takenaka, Miki
    Toh, Uhi
    Kage, Masayoshi
    Yamana, Hideaki
    Shirouzu, Kazuo
    CLINICAL MEDICINE INSIGHTS-THERAPEUTICS, 2009, 1 : 583 - 593
12345